These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27905841)

  • 1. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 as a natural and modulated target for inhibition of HIV.
    Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
    Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
    Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
    J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
    Wolstein O; Boyd M; Millington M; Impey H; Boyer J; Howe A; Delebecque F; Cornetta K; Rothe M; Baum C; Nicolson T; Koldej R; Zhang J; Keech N; Camba Colón J; Breton L; Bartlett J; An DS; Chen IS; Burke B; Symonds GP
    Mol Ther Methods Clin Dev; 2014; 1():11. PubMed ID: 26015947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
    Anderson J; Akkina R
    Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 coreceptors and their inhibitors.
    Ray N; Doms RW
    Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.
    Savkovic B; Nichols J; Birkett D; Applegate T; Ledger S; Symonds G; Murray JM
    PLoS Comput Biol; 2014 Jun; 10(6):e1003681. PubMed ID: 24945407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
    Sebastian NT; Zaikos TD; Terry V; Taschuk F; McNamara LA; Onafuwa-Nuga A; Yucha R; Signer RAJ; Riddell J; Bixby D; Markowitz N; Morrison SJ; Collins KL
    PLoS Pathog; 2017 Jul; 13(7):e1006509. PubMed ID: 28732051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
    Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
    J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV.
    Ruiz ME; Cicala C; Arthos J; Kinter A; Catanzaro AT; Adelsberger J; Holmes KL; Cohen OJ; Fauci AS
    J Immunol; 1998 Oct; 161(8):4169-76. PubMed ID: 9780190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
    Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
    J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5].
    Omelchenko DO; Glazkova DV; Bogoslovskaya EV; Urusov FA; Zhogina YA; Tsyganova GM; Shipulin GA
    Mol Biol (Mosk); 2018; 52(2):294-305. PubMed ID: 29695698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
    Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
    Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.